Biblio

Author Title [ Type(Asc)] Year
Filters: Author is Cyganek, Lukas  [Clear All Filters]
Journal Article
El-Battrawy I, Cyganek L, Zhou X, Akin I. 'Mature' resting membrane potentials in hiPSC-CMs: fact or artefact?-Authors' reply. Europace. 2019.
El-Battrawy I, Besler J, Ansari U, Liebe V, Schimpf R, Tülümen E, Rudic B, Lang S, Odening K, Cyganek L, et al. Long-term follow-up of implantable cardioverter-defibrillators in Short QT syndrome. Clin Res Cardiol. 2019.
Kruse V, Hamann C, Monecke S, Cyganek L, Elsner L, Hübscher D, Walter L, Streckfuss-Bömeke K, Guan K, Dressel R. Human Induced Pluripotent Stem Cells Are Targets for Allogeneic and Autologous Natural Killer (NK) Cells and Killing Is Partly Mediated by the Activating NK Receptor DNAM-1. PLoS One. 2015;10(5):e0125544.
Schoger E, Argyriou L, Zimmermann W-H, Cyganek L, Zelarayán LCecilia. Generation of homozygous CRISPRa human induced pluripotent stem cell (hiPSC) lines for sustained endogenous gene activation. Stem Cell Res. 2020;48:101944.
Schoger E, Zimmermann W-H, Cyganek L, Zelarayán LCecilia. Establishment of two homozygous CRISPR interference (CRISPRi) knock-in human induced pluripotent stem cell (hiPSC) lines for titratable endogenous gene repression. Stem Cell Res. 2021;55:102473.
Schoger E, Zimmermann W-H, Cyganek L, Zelarayán LCecilia. Establishment of a second generation homozygous CRISPRa human induced pluripotent stem cell (hiPSC) line for enhanced levels of endogenous gene activation. Stem Cell Res. 2021;56:102518.
Rössler U, Hennig AFloriane, Stelzer N, Bose S, Kopp J, Søe K, Cyganek L, Zifarelli G, Ali S, von der Hagen M, et al. Efficient generation of osteoclasts from human induced pluripotent stem cells and functional investigations of lethal CLCN7-related osteopetrosis. J Bone Miner Res. 2021.
Zhao Z, Li X, El-Battrawy I, Lan H, Zhong R, Xu Q, Huang M, Liao Z, Lang S, Zimmermann W-H, et al. Drug testing in human-induced pluripotent stem cell-derived cardiomyocytes from a patient with short QT syndrome type 1. Clin Pharmacol Ther. 2019.
Li W, Stauske M, Luo X, Wagner S, Vollrath M, Mehnert CS, Schubert M, Cyganek L, Chen S, Hasheminasab S-M, et al. Disease Phenotypes and Mechanisms of iPSC-Derived Cardiomyocytes From Brugada Syndrome Patients With a Loss-of-Function SCN5A Mutation. Front Cell Dev Biol. 2020;8:592893.
Khadjeh S, Hindmarsh V, Weber F, Cyganek L, Vidal RO, Torkieh S, Streckfuss-Bömeke K, Lbik D, Tiburcy M, Mohamed BA, et al. CRISPLD1: a novel conserved target in the transition to human heart failure. Basic Res Cardiol. 2020;115(3):27.